Lollipop Swab for Strep Throat

N/A

Recruiting

Led By Gregory DeMuri, MD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1 (up to 40 minutes)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a new platform for detecting Group A Streptococcus in children ages 5-17. The platform, called LolliTest, will be compared to the current gold-standard test.

Who is the study for?

This trial is for children aged 5-17 with a sore throat caused by Group A Streptococcus (GAS), confirmed by a rapid test at the clinic. They must be able to understand and complete surveys in English, as should their parents or guardians who consent on their behalf. Children sensitive to sugar-free products or unable to use the CandyCollect swab are excluded.

What is being tested?

The study tests the CandyCollect platform's ability to detect GAS from a lollipop-like swab compared to standard rapid antigen testing. It aims to prove that this new, kid-friendly method is just as accurate for diagnosing strep throat during a single clinic visit.

What are the potential side effects?

Since the intervention involves using a non-invasive candy-like swab, side effects may include discomfort from sucking on the swab and potential issues for those with sensitivity to sugar-free products.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 (up to 40 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 (up to 40 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (up to 40 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of test results positive for GAS

Secondary study objectives

Caregiver Experience Score (Bad/Good)

Caregiver Experience Score (Pleasant/Unpleasant)

Caregiver Sample Collection Preference

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Pediatric Participants with GASExperimental Treatment2 Interventions

Children age 5-17 years old diagnosed via standard Rapid Antigen Detection Test with acute pharyngitis caused by Group A Streptococcus (GAS), along with their parent or legal guardian (aka "caregiver").

Do I qualify?Apply below to find out